Hospitals may face more pricing restrictions: Icra | The Economic Times

MUMBAI: Regulatory overhang on the hospitals sector is likely to persist, with further pricing restriction expected on products and servicesNSE -1.30 % in the future, according to rating agency IcraNSE 0.45 %.

The hospitals sector has been under the regulatory scanner lately with the National Pharmaceutical Pricing Authority (NPPA) announcing price caps on stents last February and on knee implants last August.

The resultant reduction in stent prices was as much as 84 per cent, while that for knee implants was as high as 69 per cent, Icra said in its report.

Shubham Jain, vice-president, Icra, said the regulatory actions by the NPPA last year had adversely impacted the revenues and margins of the hospital players.

Read complete article here:

Hospitals may face more pricing restrictions: Icra – The Economic Times.